Canada· CA-DIN-00343617

ROFACT

A rifampicin product containing rifampin, registered in Canada by BAUSCH HEALTH, CANADA INC.. The same ATC class is registered in 18 of our 19 countries.

ATC J04AB02

Checked against Health Canada Drug Product Database (Canada) on October 1, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about rifampinAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Rifampicin is registered in 18 of 19 countries.

Countries holding a registration under ATC J04AB02 (rifampicin), each read from that country’s own register.

This record: Canada, from Health Canada Drug Product Database (Canada)
10 of them publish a price we can compare per daily dose

Search rifampicin products by name

Rifampicin · ATC J04AB02

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of rifampicin costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), the median price runs from $0.92 in Italy to $6.35 in France — a ×6.9 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Rifampicin · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

FR France$6.35
CH Switzerland$4.70
IT Italy$0.92

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Health Canada Drug Product Database (Canada)

Active substance: RIFAMPIN
Manufacturer: BAUSCH HEALTH, CANADA INC.
Country: Canada (CA)
ATC code: J04AB02
ATC class: Rifampicin
Defined daily dose: 0.6 g, O
Reimbursed: Not published by this register
Source register: Health Canada Drug Product Database (Canada)
Last checked: October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

444 interactions on record for rifampicin.

Graded by severity as the source publishes them — 144 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check rifampicin against other medicines How interaction checks work

Rifampicin · interactions on record

444 records

144 severe
173 moderate
14 minor
39 info

Most severe, free to view

RolapitantA04AD14severe
NaloxegolA06AH03severe
NaldemedineA06AH05severe
EluxadolineA07DA06severe

74 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rifampicin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rifampicin products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Eremfat, Rifoldin
Belgium · Rifadine, Rifadine I. V.
Bulgaria · Тубоцин
Cyprus · Rifasynt, Syntoren
Czechia · Benemicin
Germany · Eremfat, Eremfat I.V.
Denmark · Rimactan
Spain · Rifaldin, Rimactán
Finland · Rimapen
France · Rifadine, Rifadine Iv
United Kingdom (Northern Ireland) · Rifadin, Rifampicin Generics Uk
Croatia · Rimactan
Hungary · Rifamed
Ireland · Rifadin, Rifadin Intravenous
Iceland · Rimactan
Italy · Rifadin
Lithuania · Benemicin
Luxembourg · Rifadine
Latvia · Benemicin
Malta · Rifampicyna Tzf
Netherlands · Rifadin, Rifampicine Sandoz
Norway · Rimactan
Poland · Rifampicyna Tzf
Portugal · Rifadin, Rimactán
Romania · Rifampicină Arena, Sinerdol
Sweden · Rimactan
Slovakia · Benemicin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/df139ccc-9b82-4a6f-aa58-9b8b8dc5164a
GET /v1/drugs/df139ccc-9b82-4a6f-aa58-9b8b8dc5164a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "00343617",
  "form": "CAPSULE",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "J04AB02",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "2863",
  "strengths": [
    "300 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "RIFAMPIN"
  ],
  "product_categorization": null
}

API reference MCP server Plans

See everything about rifampicin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console